Gene Therapy Stocks List

Recent Signals

Date Stock Signal Type
2019-09-16 CRXM Pocket Pivot Bullish Swing Setup
2019-09-16 CRXM New Uptrend Bullish
2019-09-16 CRXM New 52 Week High Strength
2019-09-16 CRXM Crossed Above 20 DMA Bullish
2019-09-16 OXBDF Narrow Range Bar Range Contraction
2019-09-16 OXBDF Volume Surge Other
2019-09-16 PRVCF Lower Bollinger Band Walk Weakness
2019-09-16 PRVCF New Uptrend Bullish
2019-09-16 PRVCF 50 DMA Resistance Bearish
2019-09-16 PRVCF 20 DMA Resistance Bearish

In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989. The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990.
Between 1989 and February 2016, over 2,300 clinical trials were conducted, with more than half of them in phase I.
Not all medical procedures that introduce alterations to a patient's genetic makeup can be considered gene therapy. Bone marrow transplantation and organ transplants in general have been found to introduce foreign DNA into patients. Gene therapy is defined by the precision of the procedure and the intention of direct therapeutic effect.

More about Gene Therapy